Cometriq (cabozantinib capsules) — Cigna
Thyroid Carcinoma, Differentiated
Initial criteria
- Patient is age ≥ 12 years
- Patient has differentiated thyroid carcinoma (examples include papillary, follicular, and oncocytic carcinoma)
- Disease is refractory to radioactive iodine therapy
- Patient has tried Lenvima (lenvatinib capsules) or sorafenib tablets
Approval duration
1 year